Date post: | 30-May-2018 |
Category: |
Documents |
Upload: | metafitrian |
View: | 212 times |
Download: | 0 times |
of 38
8/14/2019 INFLAMATION_biomolsel_2008
1/38
INFLAMATION :INFLAMATION :Cellular ProcessCellular Process
Oleh:Oleh:
dr. Rahma Triliana, S.Ked. M.Kes.dr. Rahma Triliana, S.Ked. M.Kes.
Block : Cellular Moleculer BiologyBlock : Cellular Moleculer BiologyPPD UNISMAPPD UNISMA
Nopember 2008Nopember 2008
8/14/2019 INFLAMATION_biomolsel_2008
2/38
8/14/2019 INFLAMATION_biomolsel_2008
3/38
Definitions ofDefinitions of
InflammationInflammation
Its a part of Wound Healing processIts a part of Wound Healing process Protective respons induced byProtective respons induced by
cellular/tissue injury to;cellular/tissue injury to;1.1. minimize the threat to body by: diluting,minimize the threat to body by: diluting,
localising, destroying, & removing of insult orlocalising, destroying, & removing of insult orinjuryinjury
2.2. repairing damagerepairing damage
3.3. restoring normal functionrestoring normal function
Its a dynamic vascular & cellular responseIts a dynamic vascular & cellular responseto insult or injuryto insult or injury can be:can be: beneficial & protective - if regulatedbeneficial & protective - if regulated
injurious - if unregulatedinjurious - if unregulated
8/14/2019 INFLAMATION_biomolsel_2008
4/38
8/14/2019 INFLAMATION_biomolsel_2008
5/38
8/14/2019 INFLAMATION_biomolsel_2008
6/38
8/14/2019 INFLAMATION_biomolsel_2008
7/38
WHEN CELLs EXPOSED TOINJURY
8/14/2019 INFLAMATION_biomolsel_2008
8/38
CAUSESCAUSESmicroorganisms & toxinsmicroorganisms & toxins
parasitesparasites
chemical & biochemical damagechemical & biochemical damage
physical damage:physical damage:heatheat
coldcold
radiationradiation trauma -electrical -mechanicaltrauma -electrical -mechanical
immunologic: types I, III, IVimmunologic: types I, III, IV
hypersensitivityhypersensitivity
8/14/2019 INFLAMATION_biomolsel_2008
9/38
SIGNSIGNComplex ReactionsComplex Reactionsvascularvascularimmunologicalimmunological
cellularcellularClinical SignsClinical SignsRedness/RuborRedness/RuborSwelling/TumorSwelling/TumorHeat/KalorHeat/KalorPain/DolorPain/Dolorloss of function/Functiolesaloss of function/Functiolesa
8/14/2019 INFLAMATION_biomolsel_2008
10/38
TYPESTYPES
Tissue destruction,
Fibrosis
Healing, Abcess
Form., ChronicInflam.
Outcome
s
Mononuclear
(makrophages,lymphocytes, plasmacells), Fibroblast
Macrophages (as
APC), Neutrophils
Major
CellsInvolved
Up tp Months or yearsFew DaysDuration
DelayedImmediateOnset
IFN-& other Cytokines,Growth factors, ROS,
Hydrolytic Enzymes
Vasoactive Amines,eucosanoids
PrimaryMediators
Persistant inflam e.c. nondegradable pathogens,foreign bodies,autoimmune
Pathogens, InjuredTissue
Causative
CHRONICACUTE
8/14/2019 INFLAMATION_biomolsel_2008
11/38
8/14/2019 INFLAMATION_biomolsel_2008
12/38
8/14/2019 INFLAMATION_biomolsel_2008
13/38
Mediated by:Mediated by:1. Cellular products/cell derived1. Cellular products/cell derived
mediators:mediators: vasoactive aminesvasoactive amines: histamine, 5-: histamine, 5-
hydroxytryptaminehydroxytryptamine mast cells, basophils & plateletsmast cells, basophils & platelets
leads to vasodilatation & increased vascular permeabilityleads to vasodilatation & increased vascular permeability
Cytokines & ChemokinesCytokines & Chemokines (from macrophages &(from macrophages &lymphocytes)lymphocytes) polypeptides leads to increased vascular permeability &polypeptides leads to increased vascular permeability &
dilatationdilatation regulate cellular activity in inflammationregulate cellular activity in inflammation
leukocyte productsleukocyte products (enzymes & O2 radicals)(enzymes & O2 radicals) proteinases leads to degradation of membranes. & collagenproteinases leads to degradation of membranes. & collagen also chemotaxisalso chemotaxis H2O2, O2-, OH. -highly destructiveH2O2, O2-, OH. -highly destructive
products of arachadonic acid metabolismproducts of arachadonic acid metabolismeicosanoidseicosanoids
8/14/2019 INFLAMATION_biomolsel_2008
14/38
EUCOSANOIDFORMATION
8/14/2019 INFLAMATION_biomolsel_2008
15/38
Mediated by..Mediated by..
2. Plasma components/derived2. Plasma components/derived
Mediators:Mediators: kininskinins (e.g. brady kinin)(e.g. brady kinin)
protease-activated plasma proteinsprotease-activated plasma proteins potent vasodilators, increased vasc. permeability & inducepotent vasodilators, increased vasc. permeability & induce
painpain clotting & fibrinolysis systemclotting & fibrinolysis system (fibrinopeptides)(fibrinopeptides)
e.g. fibrinogen, fibrin, thrombin (coagulation system),e.g. fibrinogen, fibrin, thrombin (coagulation system),plasmin (fibrinolysis system), F-XII/Hageman Factor (activeplasmin (fibrinolysis system), F-XII/Hageman Factor (active
by kinin, fibrinolysis & coagulation system)by kinin, fibrinolysis & coagulation system)
chemotactic factors & increased vasc. permeabilitychemotactic factors & increased vasc. permeability
complement cascadecomplement cascade protease-activated plasma proteinsprotease-activated plasma proteins
mediate lytic destruction of cellsmediate lytic destruction of cells chemotaxis, histamine release, increased vascularchemotaxis, histamine release, increased vascular
8/14/2019 INFLAMATION_biomolsel_2008
16/38
8/14/2019 INFLAMATION_biomolsel_2008
17/38
8/14/2019 INFLAMATION_biomolsel_2008
18/38
EVENTS/STEPSEVENTS/STEPS
ININ
INFLAMMATIONINFLAMMATION
8/14/2019 INFLAMATION_biomolsel_2008
19/38
8/14/2019 INFLAMATION_biomolsel_2008
20/38
8/14/2019 INFLAMATION_biomolsel_2008
21/38
SEQUENCESEQUENCE
SWELLING
PAIN
- contraction of lining cells- widening of endothelial junctions
- fluid leakage (edema)
-sensory nerve irritation
2)
Permeabilitychanges
LOSS OF
FUNCTION
- local occlution of blood in capillaries &
venules
- congestion
decreased blood flow leads to hypoxia
3)
Hemostasis
REDNESS &
HEAT
- release of vasoactive substances from
damaged & aggregating cells
1)
Changes in
Blood Flow
Clinical
ResponseMechanismEvent
8/14/2019 INFLAMATION_biomolsel_2008
22/38
Sequence.Sequence.
LOSS OF
FUNCTION
connective (scar) tissue formation growth of new blood vessels replacement of destroyed cells
5)
Repair and
Regeneration
PAIN
Chemotaxis: Migration of WBC to area (neutrophilsmononuclear cells) -escape from vessels Phagocytosis:
WBCs indentify, attack, ingest & disposeof foreign matter enzymes, O2 radicals, inflam. Mediators
- removal of noxious agent, tissue debris &
fibrin
leads to further tissue damage
4)
WBC responses-Chemotaxis
-Phagocytosis
Clinical
ResponseMechanismEvent
8/14/2019 INFLAMATION_biomolsel_2008
23/38
8/14/2019 INFLAMATION_biomolsel_2008
24/38
WBC RESPONSES
8/14/2019 INFLAMATION_biomolsel_2008
25/38
8/14/2019 INFLAMATION_biomolsel_2008
26/38
FLAMMATION CAN BE GIVE LOCAL & SYSTEMIC RESPON
8/14/2019 INFLAMATION_biomolsel_2008
27/38
HARMFULHARMFUL
8/14/2019 INFLAMATION_biomolsel_2008
28/38
HARMFULHARMFULPOTENTIALSPOTENTIALS
Involved in pathogenesis of :Allergic reactions/Hypersensitivities disorder, myopathies,
immune disorders (autoimune diseases), cancer,atherosclerosis (CHD, Stroke), other degenerativesdiseases,
- Anoxia, infarcts, ischemia,shock
- Edema in lungs, abscesses- Inflam. mediators, Cytolysis,
WBC enzymes, free radicals- Arthritis, arteriosclerosis- Pyrexia, secretion- Disuse
- Altered blood supply- Space occupying
lesions- Further tissue damage
- Altered kinetic function- Altered metabolic
functions- Pain
ExamplesResponse
armful effects necessitate therapeutic intervent
8/14/2019 INFLAMATION_biomolsel_2008
29/38
8/14/2019 INFLAMATION_biomolsel_2008
30/38
8/14/2019 INFLAMATION_biomolsel_2008
31/38
Inflamation in time can resolved in-Chronic Inflammation Inflammation With ChronicSign (Inflammation with partial healing)-Repair/Healing wound Healing-Resolution Rehabilitation/proliferation back to N
state
8/14/2019 INFLAMATION_biomolsel_2008
32/38
Progress of WoundProgress of Wound-Bleeding/cell damage after injury (within hours)-Inflammation process 5 Cardinal sign of Inflammation (within 1 7 Day)-Proliferation Cell & tissue repair process begin (Days Weeks)
-Remodelling Tissue remodelling & getting back to function
8/14/2019 INFLAMATION_biomolsel_2008
33/38
O
UND
H
EA
LIN
G
8/14/2019 INFLAMATION_biomolsel_2008
34/38
8/14/2019 INFLAMATION_biomolsel_2008
35/38
8/14/2019 INFLAMATION_biomolsel_2008
36/38
8/14/2019 INFLAMATION_biomolsel_2008
37/38
8/14/2019 INFLAMATION_biomolsel_2008
38/38